Child's Nervous System

, Volume 10, Issue 4, pp 224–230 | Cite as

The Delta Valve: a physiologic shunt system

  • David A. Watson
Original Paper

Abstract

PS Medical has advanced the state-of-the-art in hydrocephalus valve technology with the introduction of the Delta Valve. The Delta Valve is designed upon the premise that the shunted patient should have intracranial pressure (ICP) maintenance within a normal range regardless of cerebrospinal fluid (CSF) flow rate or body position. All previous valves have performance characteristics that are greatly influenced by the negative hydrostatic pressure caused by the gravitational effect on the vertical water column in the distal catheter. This negative pressure influence is non-physiologic and contributes directly to overdrainage that can cause slit ventricles, subdural hematoma, and proximal catheter occlusions. The Delta Valve is the only valve that maintains a near-constant pressure gradient regardless of flow rate or patient posture. It automatically adjusts for increasing negetive pressures in the distal catheter by proportionally increasing its resistance to flow, thus nullifying the adverse effects of the hydrostatic force on intracranial pressures. The result is a shunt system that provides for CSF drainage while allowing the patient's normal physiologic conditions to control ICP. The early use of the Delta Valve in the treatment of hydrocephalus may reduce the incidence of the dramatic complications associated with overdrainage.

Key words

Hydrocephalus CSF shunting Overdrainage Intracranial pressure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Collman H, Mauersberger W, Mohr G (1980) Clinical observation and CSF absorption studies in the slit ventricle syndrome. Adv Neurosurg 8:183–186Google Scholar
  2. 2.
    Cordis Corporation (1987) Cordis Orbis-Sigma valve system for cerebrospinal fluid shunting: instructions for use. Cordis Corp, Miami, FlaGoogle Scholar
  3. 3.
    Faulhauer K, Schmitz P (1978) Overdrainage phenomena in shunt treated hydrocephalus. Acta Neurochir (Wien) 45:89–101Google Scholar
  4. 4.
    Foltz EL, Shurtleff DB (1966) Conversion of communicating hydrocephalus to stenosis or occlusion of the aqueduct during ventricular shunt. J Neurosurg 24:520–529Google Scholar
  5. 5.
    Fox JL, Portnoy HD, Schulte RR (1973) Cerebrospinal fluid shunts: an experimental evaluation of flow rates and pressure valves in the antisiphon valves. Surg Neurol 1: 299–302Google Scholar
  6. 6.
    Gruber R (1981) The relationship of ventricular shunt complications to the chronic overdrainage syndrome: a follow-up study. Z Kinderchir 34:346–352Google Scholar
  7. 7.
    Gruber R, Jenny P, Herzog B (1984) Experience with the anti-siphon device (ASD) in shunt therapy of pediatric hydrocephalus. J Neurosurg 61:156–162Google Scholar
  8. 8.
    Hirayama A (1982) Slit ventricle—a reluctant goal of ventriculoperitoneal shunt. Monogr Neural Sci 8:108–111Google Scholar
  9. 9.
    Horton D, Pollay M (1990) Fluid flow performance of a new siphoncontrol device for ventricular shunts. J Neurosurg 72:926–932Google Scholar
  10. 10.
    Horton D, Pollay M (1994) Rheological characteristics of a new siphon control device in CSF shunting systems. J Neurosurg (in press)Google Scholar
  11. 11.
    Jaskolska E, MacKinnon AE (1988) Experience with antisiphon devices: success and complications. Z Kinderchir 43:22–23Google Scholar
  12. 12.
    Kaufman B, Weiss MH, Young HF, Nulsen FE (1970), Effects of prolonged cerebrospinal fluid shunting on the skull and brain. J Neurosurg 38:288–297Google Scholar
  13. 13.
    Kiekens R, Mottier W, Pothmann R (1982) The slit-ventricle syndrome after shunting in hydrocephalic children. Neuropediatrics 13:190–194Google Scholar
  14. 14.
    Loop JE, Foltz EL (1972) Craniostenosis and diploic lamination following operation for hydrocephalus. Acta Radiol [Diagn] (Stockh) 13:8–13Google Scholar
  15. 15.
    McCullough DC (1986) Symptomatic progressive ventriculomegaly in hydrocephalics with patent shunt and antisiphon devices. Neurosurgery 4:617–621Google Scholar
  16. 16.
    McLaurin RL, Olivi A (1987) Slitventricle syndrome: review of 15 cases. Pediatr Neurosci 13:118–124Google Scholar
  17. 17.
    Oi S, Matsumoto S (1986) Morphological findings of post shunt slit-ventricle in experimental canine hydrocephalus. Aspects of causative factors of isolated ventricles and slit-ventricle syndrome. Child's Nerv Syst 2:179–184Google Scholar
  18. 18.
    Oi S, Matsumoto S (1987) Infantile hydrocephalus and slit-ventricle syndrome in early infancy. Child's Nerv Syst 3: 145–150Google Scholar
  19. 19.
    Protnoy HD, Schulte RR, Fox JL, Croissant PD, Tripp L (1973) Antisiphon and reversible occulsion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas. J Neurosurg 38:729–738Google Scholar
  20. 20.
    Pudenz RH, Foltz EL (1991) Hydrocephalus: overdrainage by ventricular shunts. A review and recommendations. Surg Neurol 35:200–212Google Scholar
  21. 21.
    Rekate HL (1988) The application of mathematical modeling to hydrocephalus research. Concepts Pediatr Neurosurg 8:1–14Google Scholar
  22. 22.
    Rekate HL, Brodkey JA, Chijzeck HJ, El Sakka W, Ko WH (1988) Ventricular volume regulation: mathematical model and computer simulation. Pediatr Neurosci 14:77–84Google Scholar
  23. 23.
    Sainte-Rose C, Hooven MD, Hirsch JF (1987) A new approach in the treatment of hydrocephalus. J Neurosurg 66:213–226Google Scholar
  24. 24.
    Samuelson S, Long DM, Chou SN (1972) Subdural hematoma as a complication of shunting procedures for normal pressure hydrocephalus. J Neurosurg 37:548–551Google Scholar
  25. 25.
    Serlo W, Heikkinen E, Saukkonen AL, Wendt L von (1985) Classification and management of the slit ventricle syndrome. Child's Nerv Syst 1:194–199Google Scholar
  26. 26.
    Tokoro K, Chiba Y (1991) Optimum position for an antisiphon device in a cerebrospinal fluid shunt system. Neurosurgery 29:519–525Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • David A. Watson
    • 1
  1. 1.Product DevelopmentPS MedicalGoletaUSA

Personalised recommendations